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Summary 
Invariant chain (Ii) contributes in a number of distinct ways to the proper functioning of major 
histocompatibility complex (MHC) class II molecules. These include promoting effective association 
and folding of newly synthesized MHC class II c~ and B subunits, increasing transit of assembled 
heterodimers out of the endoplasmic reticulum (ER), inhibiting class II peptide binding, and 
facilitating class II movement to or accumulation in endosomes/lysosomes.  Although the cytoplasmic 
tail of Ii makes a key contribution to the endocytic localization of class II, the relationship between 
the structure of Ii and its other diverse functions remains unknown. We show here that two 
thirds of the lumenal segment of Ii can be eliminated without affecting its contributions to the 
secretory pathway events of class II folding, ElK to Golgi transport,  or inhibition of peptide 
binding. These same experiments reveal that a short (25 residue) contiguous internal segment 
of Ii (the CLIP region), frequently found associated with purified MHC class II molecules, is 
critical for all three functions. Together with other recent findings, these results raise the possibility 
that the contributions of Ii to the early postsynthetic behavior of class II may depend on its 
interaction with the class II binding site. This would be consistent with the intracellular behavior 
of unoccupied MHC class I and class II molecules as incompletely folded proteins and imply 
a related structural basis for the similar contributions of Ii to class II and of short peptides to 
class I  assembly and transport. 
U 
'pon synthesis and translocation into the endoplasmic 
reticulum (ER) 1, the component chains of class I and 
class II MHC molecules need to acquire a transport-competent 
conformation for effective post-ER  transport.  To  achieve 
proper folding and a stable heavy chain-B2 microglobulin in- 
teraction suitable for secretory pathway transit, MHC class 
I molecules require binding site occupancy with short pep- 
tides primarily generated in the cytosol and imported into 
the ER via TAP (1-3). In contrast, MHC class II molecules 
assemble as a stoichiometric complex with trimers of the type 
II integral membrane glycoprotein invariant chain (Ii)  (4). 
In the secretory pathway, this association with Ii has effects 
on the properties of class II analogous to those resulting from 
peptide interaction with class I (3). Thus, interaction with 
intact Ii contributes to efficient, stable association of the class 
II c~ and j8 subunits in the ER (5, 6), promotes the transport 
of class II oe/~8 heterodimers from the ER through the Golgi 
complex (5, 7-10), and inhibits the binding of other ligands 
(peptides) to the class II molecules (11-13).  Whether these 
multiple effects of Ii require the entire molecule or are medi- 
1Abbreviations used in  this paper: endo H,  endoglycosidase  H;  ER, 
endoplasmic reticulum; Ii, invariant chain. 
ated by one or more structurally independent subregions of 
the protein is presently unknown. A particularly intriguing 
question is whether the effects of Ii on class II assembly, trans- 
port, and peptide binding represent discrete activities of this 
protein, or, as is true for short peptides binding to class I, 
whether they represent the consequences of a single under- 
lying molecular event. 
To investigate how Ii structure relates to its functions in 
the secretory pathway, and to examine the relationships be- 
tween Ii-dependent class II folding, ER to Golgi transport, 
and inhibition of peptide binding, we have studied the be- 
havior of class II molecules synthesized in the presence of 
mutant Ii proteins with truncations in the lumenal portion 
of the molecule. This strategy has allowed us to identify a 
short contiguous segment ofli that is necessary for and coor- 
dinately influences all three of these functions in the absence 
of the majority of the lumenal segment of this protein, re- 
vealing a modular structure-function organization of the Ii 
molecule. The identity of this critical region of Ii with invar- 
iant chain-derived peptides (CLIP) frequently eluted from 
purified class II molecules (14-18), when considered with other 
recent data on the structural consequences of peptide binding 
by class II molecules (18a), suggests that a common mecha- 
nism of binding site occupancy may underlie the functional 
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to  class  II  assembly  and export. 
Materials  and  Methods 
Plasmid Constructions.  cDNA expression vectors containing in- 
serts coding for various  wild-type mouse class II c~ and/3 chains 
have been previously described  (19, 20). A cDNA expression con- 
struct  containing a recombinant A3 chain with  the 31  strands 
of Aft  k and  the 31  helix  and  remaining  portion  of A  b (A~  kbb) 
was provided  by Dr.  Ned  Braunstein  (Columbia  P  &  S,  New 
York).  In the assays reported in this  study, this  construct yields 
the same results  as wild-type A/~  b when either 3  chain is coex- 
pressed  with Aoe  b. 
DNA fragments containing Ii coding sequences, 5' translation 
control elements and EcoRI, BamHI and HindIII cloning sites were 
generated by PCR amplification  (30 cycles: 94~  1 min, 55~  1 
min, 72~  2 min) using the cDNA expression construct pcEXV- 
3mii31 (19) as template and the following oligonudeotide primers: 
miil-82: upstream, 5' CCGAATTCAAGCTTACTAGAGGCTAG- 
AGCCATG 3': downstream, 5' GGAATTCCTATTATTTCGGAA- 
GCTTCATGCG 3': mIi1-107: upstream, 5' CCGAATTCAAGCT- 
TACTAGAGGCTAGAGCCATG  3'; downstream, 5' GGAATTC- 
CTATTACCCAAGGAGCATGTTATC  3'; mii19-107: upstream,  5' 
CCGAATTCAAGCTTCGTCATGAACCGCCCTAGAGAGC- 
CAGAA 3'; downstream, 5' GGAATTCCTATTACCCAAGGAG- 
CATGTTATC 3'; mii19-215: upstream, 5'CCGAATTCAAGCTT- 
CGTCATGAACCGCCCTAGAGAGCCAGAA  3'; downstream,  5' 
GGAATTCTTATCACAGGGTGACTTGACC Y.  The amplified 
fragments were digested  with EcoRI and inserted  into the EcoRI 
cloning site in the cDNA expression vector pcEXV-3. Clones with 
the insert in the proper transcriptional orientation were selected 
for use. 
Transient Expression.  For transient expression  in COS cells, a 
modified DEAE-dextran procedure (21) was used as previously de- 
scribed  (7). Briefly, COS 7.2 cells plated  at 106 per 25 cm  2 tissue 
culture flask were washed twice with DMEM/10 mM Hepes. Cells 
were then incubated in 3 ml DMEM/10 mM Hepes containing 
400/zg/ml DEAE dextran, 100 #M chloroquine, and DNA (1 #g 
of each plasmid encoding Ac~ and A3, plus 4/~g of plasmid  en- 
coding mli31, mlil-82, mli1-107,  mli19-215,  or mli19-107).  After 
4  h  at  37~  in  10%  CO2,  the  cells were  treated  with  10% 
DMSO in PBS for 2 min at room temperature,  then incubated over- 
night in DMEM/10% FCS. 48 h after transfection,  cells were used 
for immunoprecipitation,  surface  staining,  or peptide  binding. 
Metabolic Radiolabeling, Immunoprecipitation,  and  NaDod/S04/ 
Polyacrylamide Gel Analysis.  Transfected COS ceUs were incubated 
for  1  h  in  leucine-free  RPMI  1640  medium.  [3H]leucine  (500 
#Ci/ml) was then added and the cells incubated for 20 rain at 37~ 
Some samples were lysed immediately using NP40 lysis buffer (13) 
(pulse).  Other labeled cell samples were incubated for 4 h at 37~ 
in RPMI 1640 medium containing an excess of  cold leucine (chase), 
then lysed in NP40 buffer.  The precleared  lysates were immuno- 
precipitated  using mAbs previously bound to protein A-Sepharose 
beads or protein G-Sepharose beads, as previously described  (13). 
The eluted samples were analyzed by SDS-PAGE in reducing con- 
ditions. 
For  endoglycosidase  H  (endo  H)  treatment,  before  elution, 
samples were incubated in 0.05 M sodium citrate  buffer, pH 5.5, 
in the presence or absence of 15 mU ofendo H (Boehringer Mann- 
hein Corp.,  Indianapolis,  IN) at 37~  for 16 h. 
Figure  1.  (A) Schematic representation of wild-type mouse Ii31 and 
truncated forms of Ii used in this study. The exon organization of the 
Ii gene is indicated. The st@ed box represents the Ii transmembrane re- 
gion. Dotted boxes indicate Ii N-linked glycosylation sites. The putative 
binding sites of P4H5 and IN-1 mAb are indicated. Bold numbering indi- 
cates the residues at the termini of the mutant proteins. (B) Association 
of Ii mutants with MHC class II molecules. COS cells expressing either 
AoebA3  kbb plus mli1-107 or AoebA3kbb  plus mlil-82 were pulse-labeled, 
lysed in the presence of  NP40, and immunoprecipitated  with an anti-MHC 
class II mAb, M5/114, or an anti-Ii mAb, IN-1. The samples were eluted 
without heating and analyzed  by SDS gel electrophoresis. Arrows on the 
left of the figure indicate the migration of a, 3, mli1-107, and mlil-82. 
The positions of molecular weight (Mr) markers, expressed as 10 -3  x 
Mr, are indicated on the right. Similar results were obtained for Ac~bA3b, 
and in experiments in which only mli1-107 was tested, for EoeE3  d, and 
Ao~dAfl  d. 
Peptide Binding.  48 h after transfection,  COS cells were exposed 
to 100/~M biotinylated Ec~ (52-68) peptide and incubated for 4 h 
at 37~  The cells were then washed,  stained with PE-streptavidin 
for 20 min on ice, and washed twice.  The stained cells were ana- 
lyzed with a FACScan  |  using LYSYS II software (Becton Dick- 
inson & Co., Mountain View,  CA). Dead cells were eliminated 
from the analysis by staining with propidium iodide  and appro- 
priate gating. 
Su~ce Staining.  48 h after transfection, COS cells were detached 
using versene, washed twice in PBS containing 5% FCS and 0.02% 
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class II 3 chains  by stably associated  wild-type and truncated Ii. COS cells 
expressing either A~bA3  kbb (lane 1), AoebA3  kbb plus mli31 (lane 2), or 
AotbA3  kbb plus mli1-107 (lane 3) were pulse-labeled,  lysed  in the presence 
of NP-40, and immunoprecipitated  with an anti-MHC class II mAb, Y-3P. 
Arrows on the right of the figure indicate the migration of o~, mli31, 3, 
and mli1-107. The positions of molecular weight (Mr) markers, expressed 
as 10 -3  ￿  Mr, are indicated on the left. The numbers below each lane 
give the ~/3 band intensity ratio as determined by densitometric analysis. 
(B) Enhancement of MHC class II ER egress and Golgi transit by the 
mli19-107 truncated form of Ii. Metabolically  labeled  MHC class II mole- 
cules were immunoprecipitated  with the mAb Y-3P from lysates of COS 
cells after pulse-labeling  and a 4-h chase period. (Lanes I and 2), AotbA3kbb 
alone, (lanes 3 and 4) AotbA3  kbb plus mli19-107. Immunoprecipitates  were 
NAN3, and used for indirect immunofluorescence. Cells were in- 
cubated on ice either with antibodies for 20 min or with hiotinylated 
TSST-1 for 2 h and washed twice. Culture supernatants  containing 
Y-3P and M5/114 mAb were used to stain  the cells, followed by 
fluorescein isothiocyanate-conjugated goat anti-mouse or anti-rat 
immunoglobulin. Cells incubated with biotinylated TSST-1 were 
stained with PE-streptavidin. The stained cells were analyzed with 
a FACScan  |  using LYSYS II software (Becton Dickinson & Co.). 
Dead cells were eliminated from the analysis by staining and pro- 
pidium iodide and appropriate gating. Fluorescence units were cal- 
culated as the product of the mean fluorescence of all positive cells 
times the percentage of positive cells (7). 
Results and Discussion 
Because the ER-related functions of wild-type Ii involve 
stable  association  with  class  II,  we  first  established  the 
minimum  structure  necessary for such interaction,  cDNA 
expression  constructs  were  prepared  encoding  COOH- 
terminal (lumenal)  truncations  of Ii with or without  dele- 
tion of endosomal localization signals in residues 2-19 of the 
cytoplasmic tail (20, 22-24) (Fig.  1 A). Ii mutants were ex- 
pressed in COS cells together with mouse class II Ac~ and 
A3 chains and proteins from lysates of pulse-labeled cells were 
immunoprecipitated using mAbs  specific for Ac~A3 or the 
cytoplasmic tail of Ii (IN-1 [25]). mli1-107 was the shortest 
form of Ii coprecipitating with class II (Fig.  1 B).  mlil-82 
was not detectably associated with MHC class  II molecules 
in NP-40 lysates,  although  it could be readily precipitated 
by IN-1 (Fig. 1 B). Small amounts of class II were inconsis- 
tently coprecipitated with mlil-82 from digitonin lysates (data 
not shown). Thus, the exon 3-encoded region (26) between 
residues 83 and 107 of Ii makes a critical contribution to as- 
sociation with MHC class II, and sequences beyond residue 
107  are unnecessary for stable class II-Ii interaction in the 
ER.  These data on the contribution of this region to class 
II-Ii association complement those recently obtained using 
an internal  deletion approach  (27). 
The mAb Y-3P (28)  only reacts with  assembled class  II 
ot/~ dimers, and Ac~A3 dimers precipitated by Y-3P from ly- 
sates of [3H]leucine-labeled spleen cells show better labeling 
of the Ao~ than A~ chain (5, 13). Yet in Y-3P immunoprecipi- 
rates from COS cells expressing class II without Ii, a greater 
A3 than AoL signal was observed (Fig. 2 A). Recent experi- 
ments indicate that  this represents coprecipitation of unas- 
sembled, aggregated, disulphide-linked 3  chains with the small 
number of true ot/B heterodimers that form in cells lacking 
Ii (6). Strikingly, coexpression of either mli31 or mli1-107, 
but not mlil-82,  eliminated coprecipitation of these excess 
either mock treated (lanes I  and 3) or treated with endo H before gel 
analysis (lanes  2 and 4). The eluted boiled samples were analyzed  by SDS- 
PAGE under reducing conditions. Arrows on the right indicate the migra- 
tion of immature ot (o  0, immature 3 (3), mature ot (&) and mature 3 
(3'). Arrows on the left point to the positions of the molecular weight 
markers. The displayed  figure used AotbA3kbb; similar data were obtained 
using AabA3  b, and enhanced surface expression, previously shown to 
correlate  with li-dependent secretory  pathway  trafficking  (7), was also ob- 
served using A~dA3  d and A~dA3  k. 
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formation of class II heterodimers that resist interaction with 
incompletely folded proteins or their associated chaperones 
and demonstrate that the Ii segment 1-107 is both necessary 
and  sufficient for this  function. 
The contributions of Ii lumenal subregions to class II het- 
erodimer export from the ER and to inhibition  of peptide 
binding were examined using constructs lacking the endosomal 
localization signals in residues 2-19 of the Ii cytoplasmic tail 
(22, 23, 29, 30). Class II molecules expressed in cells lacking 
Ii show retention in the ER (10, 20, 23, 24) and poor acqui- 
sition of endo H resistant N-linked glycans (5, 7-10). Coex- 
pression of wild-type Ii augments the fraction of class II dimers 
acquiring endo H resistant carbohydrates. In agreement with 
our failure to detect their stable association with class II, miil- 
82, or mii19-82 had no measurable effect on class II glycan 
maturation  and mlil-82  could not be detected outside the 
ER by immunofluorescence microscopy, whether or not class 
II was also present (data not shown). In contrast, mii19-107 
was highly effective in promoting the ER. egress and medial 
Golgi transit of Y-3P-reactive class II dimers, based on their 
acquisition of endo H-resistant glycans (Fig. 2 B). As would 
be expected from  these biochemical  data,  coexpression of 
mli19-107 also increased cell surface expression of class II (data 
not  shown). 
Intact Ii inhibits stable peptide-MHC class 11 interactmn 
(11, 12), and in vitro studies with soluble synthetic peptides 
have led to the suggestion that a segment of Ii between residues 
83-107 (CLIP) is involved in this function (16,  18). To ex- 
amine whether inhibition of peptide binding mapped to this 
region  in membrane-anchored  Ii proteins,  COS cells were 
prepared that expressed on their surface class II alone (after 
intracellular  dissociation from wild-type mli31), class II stably 
assembled with mli19-107, or class II stably assembled with 
mli19-215. These cells were incubated with the biotinylated 
peptide Ec~ (52-68), then stained with PE-streptavidin. Fig. 3 
shows that  association of class  II with mli19-107,  as with 
the longer mli19-215 form, prevents formation of class II-Eoe 
(52-68) complexes. Similar results were obtained using un- 
conjugated peptide and an antibody (Y-Ae[31]) specific for 
the class II-Ec~ peptide complex, and class II-dependent pep- 
tide stimulation ofT hybridoma responses was also prevented 
by mli19-107 (data not shown). Thus, the same short 83-107 
segment of Ii makes an essential contribution  to both the 
class II assembly/transport promoting functions of Ii and to 
its  ability to inhibit  peptide binding. 
mli1-107 could carry out its functions by any of three general 
mechanisms:  (a)  It could form a cap across the superficial 
surface of the peptide binding site, preventing peptide entry 
while holding the two chains together; (b) It could bind out- 
side the binding groove, inhibiting peptide interaction by an 
allosteric change in class  II structure  that  also promotes ot 
and B chain  association;  or (c) It could lie in the binding 
groove, blocking interaction with antigenic peptides while 
providing  at least some of the stabilization  of class II that 
is characteristic of conventional binding  site occupancy. In 
an initial attempt to discriminate among these possibilities, 
A~AI~+ roll31  A~AI~ mUl 9 - 10 7 
M51114 
II  '' 
'1  'll  Eo.(52-68)  I~ 
log nuorescence 
AOA~+ mll  19 -215 
f i 
Figure  3.  Inhibition  of  antigenic peptide  binding by wild-type  and trun- 
cated Ii. COS ceUs  expressing either AotbA/~  kbb plus mli31, AotbA3  kbb plus 
mii19-107, AolbA3  kbb plus mii19-215 (solid line in each panel) or mli 31 
alone (dotted line in each panel) were examined for peptide  binding by sur- 
face class II using biotinylated Ec~ (52-68) and PE-streptavidin. The Eoe 
(52-68) peptide binds well to AotbA3kbb  and this complex reacts in our 
hands with the Y-Ae antibody in a manner similar to Ec~ (52-68) com- 
plexed with wild-type  AotbA3  b. Similar results were also obtained using 
either Ao~bA~  kbb or AotbA/~  'b with unconjugated Ea (52-68), followed 
by staining with Y-Ae mAb, and with EctEB  k and biotinylated pigeon 
cytochrome c peptide 88-104. 
we examined the effect of mli19-215 and mli19-107 associa- 
tion on class II interaction with a bacterial superantigen whose 
binding involves the class II al domain and with antibodies 
specific for the class II al  or ~1 helices.  Fig. 4 shows that 
mli19-215 association decreases  class II binding of TSST-1, 
in agreement with Karp et al. (29).  This long form of Ii also 
inhibits class II interaction  with the a  chain-specific mAb 
Y-3P, without affecting interaction with the/3 chain-specific 
mAb  M5/114.  In  contrast,  mli19-107  does not  affect  the 
binding of any of these probes to class II. Thus, the COOH- 
terminal lumenal region of Ii does show evidence of binding 
to the superficial  region of the c~ chain portion of the class 
II binding domain. Nevertheless, a shortened form ofli (mli19- 
107)  that is fully capable of inhibiting peptide binding and 
promoting proper class II structure shows no evidence of such 
interaction.  This is inconsistent with the ability of Ii to in- 
hibit peptide binding requiring superficial occlusion (capping) 
of the class II binding domain,  although the more COOH 
terminal  part  of Ii chain may have this property. 
The results presented here indicate that  an internal  seg- 
ment of invariant  chain encoded by a single exon (residues 
83-107) plays a critical role in effective Ii interaction  with 
class  II,  in  promoting  formation  of properly  folded ot/~ 
dimers, in enhancing MHC class II egress from the ER, and 
in regulating  class II peptide binding.  The more COOH- 
terminal region of Ii (from residues 108-215) is unnecessary 
for any of these secretory pathway functions. When consid- 
ered with evidence that a naturally occurring 68 residue in- 
sertion near the COOH terminus of Ii preserves interaction 
with class II but alters processed antigen presentation by these 
molecules (32), our data imply that rather than acting as a 
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Figure  4.  mli19-215 but  not 
mli19-107 association  inhibits bind- 
ing of TSST-1 or ~1 helix-specific 
mAb to class II molecules. (.4) The 
ability of AotA/J, Ac~AB + mii19- 
107, and Ac~A/~ +  mii19-215 to 
bind TSST-1. COS cells expressing 
either A~bA~  kbb, A~bA/~  kbb plus 
mii19-107, Ac~bAB  kbb plus mii19- 
215, or mli31 alone were examined 
for TSST-1 binding to surface  class 
II using biotinylated  TSST-1 (Toxin 
Technologies, Madison, WI) and 
PE-streptavidin. The results are ex- 
pressed in fluorescence units. (B) 
Ability  ofAc~A~,  AotA~ + mii19- 
107, and AotA~ +  mii19-215 to 
bind  the  mAbs Y-3P and  M5/ 
114. COS cells expressing either 
AotbAB kbb,  A~bA~  kbb plus mli19- 
107, or AotbA/3  kbb plus mii19-215 
were surface  stained with Y-3P and 
M5/114. The results are expressed 
as ratio of the fluorescence  units ob- 
tained by staining with Y-3P vs. 
the fluorescence  units obtained by 
staining with M5/114. 
single functional unit, the lumenal region of Ii is divided into 
structurally discrete subdomains with different effects on class 
II molecules at early and late times  after biosynthesis. 
Based on in vitro data using synthetic peptide versions of 
the CLIP region,  other investigators  have suggested a role 
for this portion of Ii in controlling peptide binding to class 
II (16, 18). Our results here with membrane anchored forms 
of Ii provide clear support for this model, but perhaps more 
significantly,  they also reveal  that  this  same segment  of Ii 
is involved in the control of class II heterodimer folding and 
ER to Golgi transport.  We regard as striking the functional 
similarities  between these coordinate CLIP-dependent effects 
of Ii on class II early postsynthetic behavior and the effects 
of peptide binding on class I in the ER.  In both cases, the 
interaction promotes conformationally correct MHC subunit 
interaction,  inhibits chaperone association, promotes secre- 
tory pathway transport,  and interferes with binding of other 
ligands  (3). 
How does Ii, and in particular the CLIP region, mediate 
these various effects? Our data do not rule out an allosteric 
model in which Ii interaction with class II outside the binding 
groove is the key event in regulating  all of these aspects of 
the ER/Golgi behavior of class II molecules. It is, however, 
notable that the complete CLIP segment is just slightly longer 
than a typical antigenic peptide occupying the class II binding 
site (14,  15,  17), peptides corresponding to this region of Ii 
can be eluted from purified class II molecules under the same 
conditions that release  antigenic peptides, free peptide ver- 
sions of sequences within this region bind to many different 
class II alleles and isotypes (14-18), and at least some forms 
of CLIP can promote the formation  of SDS-stable class  II 
molecules in the same manner as known groove-binding an- 
tigenic peptides (15). In contrast to many antigenic peptide 
ligands,  long  peptide  analogues  of CLIP  (16,  18)  and  all 
membrane-anchored forms of Ii containing this region ([13] 
and our unpublished observations) fail to generate the SDS- 
stable form of class II. We have recently found, however, that 
conventional antigenic peptides also can interact with class 
II in a low affinity mode that stabilizes class II structure at 
37~  without promoting the internal molecular changes in- 
volved in SDS-denaturation resistance (18a). Finally,  molec- 
ular modelling based on the recent crystal structure of class 
II (33,  34) indicates  that  an extended chain version of the 
Ii1-107 segment could reach and enter the binding site, and 
the type II membrane  orientation  of Ii would permit  this 
occupancy to occur in the NH2 to COOH orientation typ- 
ical of antigenic peptides.  These various pieces of data and 
the obvious parallels  to class I-antigenic peptide interaction 
make  attractive  a  model in  which  the  CLIP region  plays 
the role  of a  low  to  moderate  affinity,  "generic"  class  II 
groove-occupying peptide while it is still a part of the intact 
Ii structure. This could promote heterodimer stability in the 
organelles of the secretory pathway while precluding inter- 
action with other potential ligands until Ii is removed by pro- 
teolytic processing in endosomes/-prelysosomes. 
Other parts of Ii, including possibly a portion of CLIP 
that  extends out of the binding  site proper,  may affect the 
ability of class II to undergo the intramolecular  rearrange- 
ments involved in very stable peptide binding (35, 36), helping 
to assure that CLIP does not become too tightly associated 
with class II. Distinct regions of intact Ii clearly contact class 
II, which may help strengthen  the low affinity association 
of the CLIP segment with diverse binding sites,  yet allow 
effective dissociation after partial Ii proteolysis in the endo- 
cytic pathway. CLIP control of binding site availability would 
affect where within  the endosomal pathway class  II mole- 
1111  Romagnoli  and Germain cules can be loaded with antigenic peptides, as it is necessary 
to  remove  this  region  prior  to  effective  association with 
processed antigen. This event appears to be critically depen- 
dent on the expression of the DMA and DMB genes of the 
MHC (37,  38). 
The MHC class II binding site allows occupancy with long 
peptides (35) and even unfolded segments of intact proteins 
(39).  Thus,  the ability of Ii to interfere with binding site 
function may be critical to the export of useful class II mole- 
cules to the relevant antigen processing compartment. Class 
II might otherwise interact unproductively with exposed pep- 
tide segments of the incompletely folded proteins present in 
high concentration in the ER lumen, in a manner analogous 
to the presumed binding of class II to denatured protein an- 
tigens in endosomes/lysosomes (3).  This interference with 
unproductive ER binding to class II to large proteins seems 
to be the relevant  consequence of Ii inhibition of binding 
site function, not the prevention of  binding of the short pep- 
tides that are  the ligands of class I  (5). 
MHC molecules lacking binding site ligands behave within 
cells  as  incompletely folded proteins.  The  dichotomy in 
preferred  sites of antigenic peptide acquisition by class I and 
class'II molecules, despite initial formation of both classes 
of binding sites in the ER, demands distinct solutions to the 
occupancy requirement for folding compatible with secre- 
tory pathway transport. Previous studies have shown that Ii 
provides  for class II the ER functions performed by short 
antigenic peptides for class I (5). The present study suggests 
that this similarity may be more than superficial,  possibly 
involving the direct occupancy of the class II binding site 
with an internal Ii segment. 
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